Noom Med's prior authorization support applies only to its branded-medication track, and even with help, PA can take up to two weeks, with appeals taking up to 90 days.
If you'd rather not wait on a prior authorization decision at all, Luma Health's compounded semaglutide ($197/month) and tirzepatide ($297/month) don't require insurance approval to start.
Noom Med offers two distinct paths: a compounded GLP-1 program that doesn't involve insurance at all, and a branded-medication telehealth track specifically built around helping patients access insurance-covered Wegovy, Zepbound, Ozempic, or similar medications. If you're researching Noom Med's prior authorization support, it's worth understanding which track that applies to and what the realistic timeline looks like.
How Noom Med's Insurance Support Works
For patients pursuing branded medication, Noom Med offers a free insurance coverage checker — you submit basic details from your insurance card, and their team contacts your insurer directly to confirm coverage, copay estimates, and prior authorization requirements, typically returning results within minutes to a short wait. If a prior authorization is required, Noom Med's clinical team can submit that request on your behalf as part of the branded-medication telehealth visit.
The Realistic Timeline
Published reporting on Noom Med's process indicates prior authorization requests can take up to two weeks to resolve, and if the initial request is denied, an appeal can take up to 90 days. This is a meaningful commitment of time, and it's worth planning around rather than assuming coverage will be sorted out quickly. Compounded medication plans, by contrast, don't involve this insurance-verification step at all, since they're offered on a cash-pay basis.
It's easy to conflate Noom's various program tiers. The compounded GLP-1Rx programs bundle medication into a flat cash price and skip insurance entirely. The branded-medication telehealth track is priced separately from medication and is specifically built for patients who want to use insurance — that's the track where prior authorization support applies.
What to Expect If You Use This Support
You'll typically start with the free coverage checker to understand your baseline coverage and estimated copay before committing to anything. If you proceed and a prior authorization is needed, Noom's care coordinators handle the submission and follow-up, aiming to respond to patient questions within about 24 hours. If your request is denied, ask specifically what appeal support is included and what documentation the appeal will need — a well-documented appeal, addressing the specific denial reason, meaningfully improves the odds of a reversal.
A Bridge Option While You Wait
Given that PA can take up to two weeks and an appeal up to 90 days, some patients choose to start a cash-pay compounded option while their insurance process plays out, then switch to insurance-covered brand medication if and when it's approved. This avoids an extended treatment gap during a lengthy administrative process.
Which Path Fits You
- Have commercial insurance and specifically want brand-name medication
- Are comfortable with a process that can take up to two weeks (or 90 days on appeal)
- Want an insurance coverage check before committing
- Don't want to wait on a prior authorization decision
- Don't have insurance coverage for weight-loss GLP-1s
- Want to start treatment this week rather than in a few weeks
Skip the wait.
No prior authorization needed.
Compounded semaglutide at $197/month or tirzepatide at $297/month, flat — no insurance approval required to start.
Get Started → Or start your free health assessmentFrequently Asked Questions
No, only for its branded-medication telehealth track. The compounded GLP-1Rx programs are cash-pay and don't involve insurance or prior authorization at all.
Published reporting indicates up to two weeks for an initial request, with appeals taking up to 90 days if the first request is denied.
Yes. Noom Med offers a free insurance coverage checker where their team contacts your insurer directly and returns an estimated copay and PA requirements, typically within minutes.
Ask what appeal support is included and what documentation is needed. A well-documented appeal addressing the specific denial reason meaningfully improves the odds of reversal, though the process can take up to 90 days.
Yes, by choosing a cash-pay compounded option, which doesn't require insurance approval to start. Some patients use this as a bridge while a separate PA process plays out.
No. Luma Health's compounded semaglutide and tirzepatide are cash-pay, flat-rate options that don't require insurance approval or prior authorization to begin.
References
- American Medical Association. Prior authorization resources. AMA-assn.org. AMA-assn.org
- U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov. 2025. FDA Drug Approvals Database
- Mercer. National Survey of Employer-Sponsored Health Plans, 2025: GLP-1 coverage findings. Mercer.com. 2025. Mercer.com
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov